|
FDA Warns Canadian Pharmacy for Trying to Sell Unapproved Drug to Onfi Patients
The FDA is warning a pharmacy in Vancouver for continuing to sell its unapproved clobazam to U.S. patients despite the agency’s approval of Lundbeck’s Onfi in 2011.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives